drug
Descartes-08
Phase 3updated 5mo agoby $RNAC Cartesian Therapeutics, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Descartes-08
- phase2Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
- phase2Descartes-08 in Autoantibody Myositis
- phase2Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- phase2Descartes-08 for Patients With Systemic Lupus Erythematosus
- phase1Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
News(1)
- CAR Ts will only treat autoimmune diseases if we can scale deliveryBiopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in the provider ecosystem and clinical infrastructure, as well as access and…biospace · 1mo ago
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that